Boditech Med Inc
KOSDAQ:206640
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12 450
18 040
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Boditech Med Inc
Boditech Med Inc
Balance Sheet
Boditech Med Inc
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
1 792
|
16 391
|
13 035
|
22 776
|
26 045
|
23 820
|
24 045
|
38 817
|
26 262
|
42 494
|
47 944
|
|
| Cash |
0
|
0
|
8
|
5
|
295
|
3 115
|
7
|
3
|
2
|
1
|
3
|
|
| Cash Equivalents |
1 792
|
16 391
|
13 027
|
22 771
|
25 750
|
20 705
|
24 038
|
38 814
|
26 259
|
42 493
|
47 941
|
|
| Short-Term Investments |
8 540
|
7 873
|
641
|
8 651
|
3 127
|
984
|
34 298
|
29 641
|
34 185
|
33 689
|
13 765
|
|
| Total Receivables |
5
|
13 652
|
14 290
|
12 949
|
14 541
|
15 943
|
35 611
|
26 846
|
23 442
|
28 602
|
31 328
|
|
| Accounts Receivables |
5
|
10 547
|
13 942
|
11 677
|
13 997
|
14 357
|
33 882
|
24 738
|
22 155
|
26 702
|
29 350
|
|
| Other Receivables |
0
|
3 105
|
348
|
1 272
|
544
|
1 586
|
1 729
|
2 108
|
1 287
|
1 899
|
1 978
|
|
| Inventory |
0
|
5 257
|
9 417
|
12 183
|
15 202
|
14 691
|
24 063
|
33 410
|
30 849
|
31 603
|
38 754
|
|
| Other Current Assets |
0
|
1 499
|
4 168
|
2 746
|
3 904
|
2 279
|
3 423
|
2 369
|
2 569
|
2 291
|
4 031
|
|
| Total Current Assets |
10 337
|
44 671
|
41 552
|
59 304
|
62 819
|
57 717
|
121 440
|
131 083
|
117 307
|
138 679
|
135 822
|
|
| PP&E Net |
0
|
19 749
|
25 448
|
27 675
|
28 754
|
31 362
|
30 790
|
45 360
|
58 158
|
56 441
|
61 871
|
|
| PP&E Gross |
0
|
0
|
25 448
|
27 675
|
28 754
|
0
|
30 790
|
45 360
|
58 158
|
56 441
|
61 871
|
|
| Accumulated Depreciation |
0
|
0
|
7 528
|
10 179
|
13 344
|
0
|
22 216
|
27 064
|
33 049
|
39 260
|
44 586
|
|
| Intangible Assets |
0
|
2 712
|
6 546
|
6 162
|
5 317
|
4 792
|
4 346
|
4 156
|
5 116
|
5 204
|
5 806
|
|
| Goodwill |
0
|
0
|
14 167
|
9 082
|
2 496
|
2 496
|
316
|
316
|
316
|
316
|
316
|
|
| Note Receivable |
0
|
2 880
|
778
|
1 412
|
1 104
|
947
|
987
|
755
|
979
|
863
|
893
|
|
| Long-Term Investments |
0
|
1 457
|
1 552
|
1 873
|
1 672
|
2 444
|
4 543
|
7 462
|
10 185
|
21 849
|
46 225
|
|
| Other Long-Term Assets |
0
|
236
|
748
|
2 658
|
1 280
|
1 504
|
1 052
|
3 110
|
3 595
|
4 550
|
3 741
|
|
| Other Assets |
0
|
0
|
14 167
|
9 082
|
2 496
|
2 496
|
316
|
316
|
316
|
316
|
316
|
|
| Total Assets |
10 337
N/A
|
71 705
+594%
|
90 792
+27%
|
108 166
+19%
|
103 442
-4%
|
101 262
-2%
|
163 475
+61%
|
192 242
+18%
|
195 656
+2%
|
227 902
+16%
|
254 674
+12%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
5 043
|
4 065
|
3 490
|
1 606
|
1 319
|
6 146
|
6 417
|
1 580
|
5 238
|
5 458
|
|
| Accrued Liabilities |
0
|
0
|
2 311
|
2 226
|
3 032
|
2 607
|
3 808
|
4 485
|
5 050
|
5 538
|
6 345
|
|
| Short-Term Debt |
0
|
1 300
|
2 300
|
14 162
|
5 300
|
1 160
|
5 460
|
2 350
|
3 976
|
7 059
|
6 729
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
400
|
55
|
2 049
|
9 572
|
3 005
|
2 050
|
1 749
|
859
|
1 118
|
|
| Other Current Liabilities |
128
|
2 896
|
2 614
|
2 173
|
2 722
|
2 502
|
14 883
|
11 811
|
3 766
|
8 571
|
7 735
|
|
| Total Current Liabilities |
128
|
9 238
|
11 690
|
22 105
|
14 709
|
17 160
|
33 301
|
27 113
|
16 121
|
27 264
|
27 386
|
|
| Long-Term Debt |
1 301
|
2 690
|
0
|
14 195
|
19 085
|
5 251
|
3 460
|
2 465
|
3 170
|
2 650
|
3 239
|
|
| Deferred Income Tax |
43
|
0
|
1 128
|
738
|
596
|
531
|
418
|
1 052
|
1 053
|
523
|
444
|
|
| Minority Interest |
0
|
111
|
2 322
|
2 467
|
2 692
|
3 560
|
6 242
|
10 145
|
11 276
|
11 218
|
12 783
|
|
| Other Liabilities |
0
|
273
|
484
|
790
|
1 029
|
1 213
|
195
|
379
|
481
|
48
|
552
|
|
| Total Liabilities |
1 472
N/A
|
12 312
+736%
|
15 624
+27%
|
40 295
+158%
|
38 110
-5%
|
27 715
-27%
|
43 616
+57%
|
41 154
-6%
|
32 101
-22%
|
41 703
+30%
|
44 405
+6%
|
|
| Equity | ||||||||||||
| Common Stock |
460
|
20 988
|
21 165
|
23 301
|
23 418
|
23 469
|
23 487
|
23 487
|
23 487
|
23 487
|
23 487
|
|
| Retained Earnings |
7
|
19 740
|
32 345
|
28 118
|
26 019
|
36 512
|
80 963
|
120 722
|
140 603
|
163 342
|
186 207
|
|
| Additional Paid In Capital |
8 411
|
12 807
|
24 262
|
22 276
|
21 987
|
21 207
|
19 934
|
18 684
|
18 719
|
18 719
|
18 897
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
729
|
880
|
650
|
565
|
559
|
546
|
1 755
|
|
| Treasury Stock |
0
|
0
|
3 057
|
3 829
|
3 829
|
6 617
|
5 813
|
14 539
|
21 587
|
21 573
|
24 429
|
|
| Other Equity |
0
|
5 858
|
452
|
1 995
|
1 535
|
143
|
1 937
|
3 300
|
2 892
|
2 769
|
4 353
|
|
| Total Equity |
8 865
N/A
|
59 393
+570%
|
75 167
+27%
|
67 872
-10%
|
65 332
-4%
|
73 547
+13%
|
119 859
+63%
|
151 088
+26%
|
163 555
+8%
|
186 198
+14%
|
210 269
+13%
|
|
| Total Liabilities & Equity |
10 337
N/A
|
71 705
+594%
|
90 792
+27%
|
108 166
+19%
|
103 442
-4%
|
101 262
-2%
|
163 475
+61%
|
192 242
+18%
|
195 656
+2%
|
227 902
+16%
|
254 674
+12%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
1
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
22
|
22
|
22
|
|
